Q4 2024 · 13F-HR
Exome Asset Management LLCholdings as filed
Filed 2025-02-14 · accession 0001420506-25-000519
$133.1M
Reported value
59
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $6.8M | 5.09% | 246,700 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $6.4M | 4.78% | 8,247 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $5.6M | 4.22% | 1,561,152 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $4.6M | 3.44% | 18,066 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $4.5M | 3.39% | 147,800 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $4.5M | 3.35% | 1,083,487 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $4.4M | 3.29% | 69,072 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $4.2M | 3.17% | 318,900 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $4.2M | 3.15% | 218,700 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $4.1M | 3.10% | 151,965 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $3.9M | 2.91% | 7,427 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $3.8M | 2.86% | 119,467 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $3.7M | 2.77% | 65,200 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $3.6M | 2.72% | 40,500 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $3.6M | 2.67% | 22,450 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $3.5M | 2.61% | 77,285 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $3.3M | 2.51% | 77,439 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $3.2M | 2.39% | 40,580 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $3.1M | 2.33% | 65,883 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $2.8M | 2.08% | 31,800 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $2.7M | 2.06% | 29,700 | Common | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS INC | $2.3M | 1.75% | 130,412 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $2.3M | 1.73% | 137,716 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $2.2M | 1.63% | 81,473 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $2.1M | 1.61% | 40,123 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $2.1M | 1.61% | 699,698 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $2.1M | 1.61% | 61,367 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $2.1M | 1.61% | 9,000 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $2.0M | 1.51% | 159,552 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $1.9M | 1.43% | 68,608 | Common | SOLE |
| 256135203 | RDY | DR REDDYS LABS LTD | $1.9M | 1.39% | 117,500 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $1.8M | 1.39% | 10,000 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $1.8M | 1.32% | 225,323 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $1.6M | 1.17% | 28,178 | Common | SOLE |
| 48576UAA4 | — | KARYOPHARM THERAPEUTICS INC | $1.6M | 1.17% | 2,000,000 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $1.4M | 1.02% | 103,504 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $1.3M | 1.00% | 283,599 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $1.2M | 0.94% | 113,096 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $1.2M | 0.92% | 37,600 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $1.2M | 0.90% | 26,081 | Common | SOLE |
| L01800108 | ALVO | ALVOTECH | $1.2M | 0.90% | 90,100 | Common | SOLE |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $1.2M | 0.89% | 353,434 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $1.1M | 0.79% | 256,373 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $1.1M | 0.79% | 28,159 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $993,250 | 0.75% | 1,097,999 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $965,546 | 0.73% | 389,333 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $742,978 | 0.56% | 144,830 | Common | SOLE |
| 92536C103 | VERUEUR | VERU INC | $739,509 | 0.56% | 1,117,600 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $736,126 | 0.55% | 234,435 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $662,877 | 0.50% | 54,738 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $603,517 | 0.45% | 13,100 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $574,902 | 0.43% | 618,174 | Common | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $419,709 | 0.32% | 127,960 | Common | SOLE |
| 00972D105 | AKBA | AKEBIA THERAPEUTICS INC | $391,316 | 0.29% | 205,956 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $304,559 | 0.23% | 987 | Common | SOLE |
| 52187K200 | CYPH | LEAP THERAPEUTICS INC | $295,064 | 0.22% | 102,631 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $249,723 | 0.19% | 172,924 | Common | SOLE |
| 640979900 | — | NEUMORA THERAPEUTICS INC. | $207,000 | 0.16% | 600 | CALL | SOLE |
| 03879J100 | ABUS | ARBUTUS BIOPHARMA CORP | $92,541 | 0.07% | 28,300 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.